SEPTEMBER 2024 NEWSLETTER
The newsletter of the Feinberg School of Medicine Research Office
 |
Feinberg Receives Record Research Funding |
|
Feinberg principal investigators secured $742.2 million dollars in research funding and awards during the 2023-24 fiscal year, which is a five percent increase over the previous year, and the largest amount in the school’s history. |
 |
Research Day 2024 Celebrates Scientific Discovery and Advances |
|
Feinberg students, staff, trainees and faculty gathered to celebrate scientific discovery and presented research posters and abstracts at Feinberg’s 18th annual Lewis Landsberg Research Day on Thursday, September 12. |
 |
Northwestern Receives $55 Million to Advance Health Research |
|
The Northwestern University Clinical and Translational Sciences (NUCATS) Institute has received $55 million in National Institutes of Health (NIH) funding to accelerate development, evaluation and implementation of improved healthcare interventions. |
Register NowNemmers Prize LectureNemmers Prize Recipient Jeffrey Gordon, MD, a distinguished university professor at Washington University in St. Louis, will discuss the microbiome-targeted therapies for childhood undernutrition on September 30. |
|
Faculty ProfileUnderstanding How Inflammation Contributes to Cardiovascular DiseaseMatthew Feinstein, ’11 MD, ’17 MSc, is an associate professor of Medicine in the Division of Cardiology, of Preventive Medicine in the Division of Epidemiology, and of Pathology. He is also the director of Northwestern's Clinical and Translational Immunocardiology Program and director of medical student research at Feinberg. |
|
Staff ProfileSupporting Women’s Health ResearchTakelia Walker is an associate department administrator in the Department of Obstetrics and Gynecology at Feinberg. A lifelong Chicagoan, Walker was born and raised on the south side of Chicago and has been with Northwestern since 2008. |
|
Student ProfileStudying the Genetic Drivers of Rare Developmental DisordersAishwarya Ramamurthy is a fifth-year student in the Driskill Graduate Program in Life Sciences (DGP). She works in the laboratory of Gemma Carvill, PhD, assistant professor in the Ken and Ruth Davee Department of Neurology Division of Epilepsy and Clinical Neurophysiology, where she studies the genetic drivers of rare developmental disorders. |
|
Campus Events |
||||||||
|
Research in the NewsNew York Times, August 27 Crain's Chicago Business, August 13 FOX 32 Chicago, August 13 |
NUCATS CornerNew Funding Available for Northwestern FacultyThe Northwestern University Clinical and Translational Sciences (NUCATS) Institute has released requests for applications for a pair of funding opportunities. The Joseph & Dorothy Giddan Child Health Research Awards initiative is seeking proposals for highly innovative, lab-based basic or lab-based translational research projects that expand the knowledgebase in the field of child health. The maximum award is $200,000 over two years. The Eisenberg Pilot Awards aim to support innovative projects that bridge the gap between research laboratories and the clinical introduction of new therapies or devices, ultimately benefiting patients. The maximum award is $25,000. Both awards have an application deadline of November 1. |
|
Sponsored ResearchHealth Equity and Access to Leverage Technology for Improved Diabetic Retinopathy Outcomes (HEAL-DR)
|
Sponsored ResearchMosaic: RCT of a Digital Health Intervention Delivering Peer Support Narratives and Psychoeducation to English- and Spanish-Speaking Stem Cell Transplant Recipients
|
Breakthroughs PodcastOvercoming Hormone Therapy Resistance in Prostate Cancer with Sarki Abdulkadir, MD, PhDIn this episode, Sarki Abdulkadir, MD, PhD, shares how his team bucked the conventional notion that the MYC gene is “undruggable” and uncovered a handful of compounds that block MYC gene activity, making prostate cancer tumors sensitive to hormone therapy and opening up a potential new therapeutic target for treatment-resistant prostate cancer. |
|
New FacultyBrandon Jutras, PhD, joined Feinberg in June 2024 as an associate professor of Microbiology-Immunology. Previously he was associate professor in the Department of Biochemistry and Fralin Life Sciences Institute at Virginia Tech. His research has focused on studying the biology and pathogenesis of spirochetes with an emphasis on the agents that cause Lyme disease and syphilis. Jutras earned his PhD in Microbiology from the College of Medicine at University of Kentucky, prior to being a Howard Hughes Medical Institute postdoctoral fellow at Yale University. His innovative diagnostic project was selected for a 2021 Emerging Leader Award. |
|
Galter LibraryApproaching Two Years of the NIH Data Management and Sharing (DMS) PolicyA wide range of local efforts have been implemented to support compliance with the DMS Policy. The Galter Library team held meetings throughout 2023 with departments and individuals to update them on the new requirements. |
|
High Impact ResearchLi R, Shah PH, Stewart TF, Nam JK, Bivalacqua TJ, Lamm DL, Uchio EM, Geynisman DM, Jacob JM, Meeks JJ, Dickstein R, Pearce SM, Kang SH, Jung SI, Kamat AM, Burke JM, Keegan KA, Steinberg GD. Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial. Nature Medicine. August 2024; 30(8):2216-2223. McElvaney OJ, McMahon GT. International Medical Graduates and the Physician Workforce. JAMA. 2024; 332(6):490-496. Moreno-Domínguez A, Colinas O, Arias-Mayenco I, Cabeza JM, López-Ogayar JL, Chandel NS, Weissmann N, Sommer N, Pascual A, López-Barneo J. Hif1α-dependent mitochondrial acute O2 sensing and signaling to myocyte Ca2+ channels mediate arterial hypoxic vasodilation. Nature Communications. August 2024; 15(1):6649-6649. Morschhauser F, Dahiya S, Palomba ML, Martin Garcia-Sancho A, Reguera Ortega JL, Kuruvilla J, Jäger U, Cartron G, Izutsu K, Dreyling M, Kahl B, Ghesquieres H, Ardeshna K, Goto H, Barbui AM, Abramson JS, Borchmann P, Fleury I, Mielke S, Skarbnik A, de Vos S, Kamdar M, Karmali R, Viardot A, Farazi T, Fasan O, Lymp J, Vedal M, Nishii R, Avilion A, Papuga J, Kumar J, Nastoupil LJ. Lisocabtagene maraleucel in follicular lymphoma: the phase 2 TRANSCEND FL study. Nature Medicine. August 2024; 30(8):2199-2207. |
Featured CoreProteomics CoreThe mission of Northwestern Proteomics is to develop new proteomics technologies; to apply them to timely questions in basic, translational and clinical research; to educate researchers throughout the Chicagoland area; and to communicate our research findings to the wider scientific community. Services Offered
|
NIH NewsFiscal Year 2025 NIH Loan Repayment Program Cycle Is Open Until November 21, 2024 In fiscal year (FY) 2024, the NIH funded nearly three-quarters of NIH Loan Repayment Program (LRP) applications, an incredible success rate. With that momentum in mind, the NIH is excited to announce that applications for the FY 2025 cycle are now being accepted until November 21, 2024. Those interested are encouraged to apply. The Extramural LRP was developed to recruit and retain highly qualified biomedical and behavioral researchers within the research workforce. It does this by offering to repay up to $100,000 of qualified educational debt in exchange for a two-year commitment to research. To be eligible, you must be a qualified health professional engaged in NIH-mission relevant research for at least 20 hours per week at a nonprofit or government institution. Navigate NIH Grants Policies in FY2025 with Confidence Webinar Registration Now Open Mark your calendar and join peers for the upcoming webinar, NIH Grants Policy Updates: FY2025 Edition, on October 17, 2024, from 1:00 to 2:00 p.m. ET. This live, virtual event is an invaluable opportunity for grant administrators, research compliance officers, and anyone involved with NIH grants to stay informed on the latest policy news. Expert presenters from the NIH Office of Extramural Research will cover crucial updates on grant policies, systems and resources, and discuss how these changes could affect your institution’s compliance processes. Attendees can submit questions during registration, which may be addressed during the live Q&A session. Ensure you and your team are prepared for the upcoming fiscal year. |
Funding Opportunities
Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)
|
Thank You For ReadingWe welcome your feedback. Please share it with us via email. |
|
|
